Bergese SD, Melson T, Candiotti KA, Ayad SS, Mack RJ, McCallum SW, Du W, Gomez A, Marcet JE. A Phase 3, Randomized, Placebo‐Controlled Evaluation of the Safety of Intravenous Meloxicam Following Major Surgery. Clin Pharmacol Drug Dev. 2019 Feb 20.; Publish Ahead of Print: https://doi.org/10.1002/cpdd.666.
In regards to the published paper entitled, “A Phase 3, Randomized, Placebo‐Controlled Evaluation of the Safety of Intravenous Meloxicam Following Major Surgery,” a correction needs to be noted on page 22, Table 1. Referring to “time (hours) from end of surgery to first dose, mean ± SD,” the number was previously 12.5 but has been changed to 1.25 due to a typographical error.